Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis
Status:
Terminated
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy and safety of a combination product S2G6T-1 compared to its monads and
vehicle, applied twice daily for 7 days, in the treatment of symptomatic inflammatory
interdigital tinea pedis in subjects 12 years of age and older. The results of this study
will be utilized to perform power calculations for the Phase 3 pivotal trials.